$4.5

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital HeidelbergInvestment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

Investment of Approx. USD 4.5 Million in Development of Diagnostics for Tuberculosis to Partners Including Fujirebio and University Hospital Heidelberg

TOKYO, April 23, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 679 million…

1 week ago
Synata Bios Sylonto Project Awarded $4.5 Million NDRC GrantSynata Bios Sylonto Project Awarded $4.5 Million NDRC Grant

Synata Bios Sylonto Project Awarded $4.5 Million NDRC Grant

WARRENVILLE, Ill., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Synata Bio, a U.S. company delivering turnkey carbon utilization technology to transform…

5 months ago